Inuniv and Working Memory

Completed · Phase 4

Conditions studied: Attention Deficit Hyperactivity Disorder

In brief

Minimum 24 subjects aged 8-12 with a diagnosis of ADHD will be prescribed extended release guanfacine (Intuniv) to assess impact, if any, on working memory. Pre and post testing using a standardized battery of tests for effect on symptoms of ADHD and working memory will be administered and assessed.

Key facts

Study ID

NCT01177306

Run by

Lori A. Schweickert, MD

People needed

18

Starts

2010-07-01

Expected to finish

2014-05-01

Last updated by the study team

2014-07-28

Who can join

Age: 8 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet DSM-IV criteria for ADHD, combined, inattentive, or hyperactive/impulsive subtype, as evidenced by minimum score of 24 on the ADHD-RS-IV at baseline
• 2 Outpatient status
• 3. Age 8-12 (inclusive) at baseline
• 4. Males or Pre-menarchal females
• 5. English-speaking parent and subject
• 6. If on stimulant medication, has demonstrated sub-optimal response to treatment ad is willing to be washed out (discontinued) from stimulant
• 7. Intellectual capacity to provide assent, as deemed by the Principal Investigator
• 8. No known cardiac history, including bradycardia, heart block, syncope or tachycardia
• 9. No known history of hypotension or hypotension at baseline
• 10. Willing to provide informed consent/ assent per IRB protocol

You may not qualify if…

• • 1.Meet DSM-IV criteria for ADHD, combined, inattentive, or hyperactive/impulsive subtype, as evidenced by minimum score of 24 on the ADHD-RS-IV at baseline
• 2 Outpatient status
• 3. Age 8-12 (inclusive) at baseline
• 4. Males or Pre-menarchal females
• 5. English-speaking parent and subject
• 6. If on stimulant medication, has demonstrated sub-optimal response to treatment ad is willing to be washed out (discontinued) from stimulant
• 7. Intellectual capacity to provide assent, as deemed by the Principal Investigator
• 8. No known cardiac history, including bradycardia, heart block, syncope or or tachycardia
• 9. No known history of hypotension or hypotension at baseline
• 10. Willing to provide informed consent/ assent per IRB protocol 11. No history of hepatic or renal impairment

Where it is running

• 3C Family Services — Cary, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.